Julie K. Olson

Julie K. Olson

Auto-generated profile, based on publicly available information

Julie K. Olson

Department of Diagnostic and Biological Sciences, School of Dentistry University of Minnesota Minneapolis Minnesota USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
MBMandy Boontanrart
Mandy Boontanrart
SHSamuel D. Hall
Samuel D. Hall
JSJustin A. Spanier
Justin A. Spanier
CHColleen E. Hayes
Colleen E. Hayes
JOJulie K. Olson
Julie K. Olson

13 August 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
NLNhungoc Luong
Nhungoc Luong
JOJulie K. Olson
Julie K. Olson
Microglia become persistently infected during Theiler’s murine encephalomyelitis virus (TMEV) infection in the central nervous system (CNS) of susceptible mice. We have previously shown that microglia infected with TMEV become activated through the innate immune receptors to express type I interferons, cytokines, and chemokines. Persistent TMEV infection in the CNS promotes chronic neuroinflammation and development of demyelinating disease similar to multiple sclerosis. In the current studies, we wanted to determine whether TMEV-infected microglia secrete exosomes which contribute to neuroinflammation in the CNS thus promoting the development of demyelinating disease. Exosomes are vesicles containing RNA, DNA, and proteins that are released from one cell and taken up by another cell to facilitate communication between cells. These studies isolated exosomes secreted by microglia during TMEV infectionin vitroas well as exosomes secreted by microglia during early TMEV infection in mice. These studies show that microglia secrete exosomes during TMEV infection which contain the viral RNA coding region. The exosomes secreted by microglia during TMEV infection can be taken up by uninfected bystander cells, including CNS resident microglia, astrocytes, and neurons. The viral RNA in the exosomes can be transferred to the bystander cells. In addition, the bystander cells that took up these exosomes were activated through the innate immune response to express type I interferons, IFNα and IFNβ, pro-inflammatory cytokines, IL-6, IL-12, and TNFα, and chemokines, CCL2. Most interestingly, exosomes secreted by microglia during early TMEV infection in mice activated an inflammatory response when transferred to the brains of naïve mice. These results show that exosomes secreted by microglia during early TMEV infection contain viral RNA and can activate uninfected bystander CNS cells to promote an inflammatory immune response. Thus, exosomes secreted by microglia during virus infection may promote viral persistence and neuroinflammation which contributes to the development of demyelinating disease.

Verified
Journal Article
Open access
PDF file
FSFaezeh Sahebdel
Faezeh Sahebdel
AZALi Zia
ALi Zia
HQHector Ramiro Quinta
Hector Ramiro Quinta
LMLeslie R. Morse
Leslie R. Morse
JOJulie K. Olson
Julie K. Olson
RBRicardo A. Battaglino
Ricardo A. Battaglino
Neuropathic pain resulting from spinal cord injury (SCI) is a significant secondary health issue affecting around 60% of individuals with SCI. After SCI, activation of microglia, the immune cells within the central nervous system, leads to neuroinflammation by producing pro-inflammatory cytokines and affects neuropathic pain. This interplay between inflammation and pain contributes to the persistent and intense pain experienced by many individuals with SCI. MicroRNAs (miRs) have been critical regulators of neuroinflammation. Previous research in our laboratory has revealed upregulation levels of circulating miR-19a and miR-19b in individuals with SCI with neuropathic pain compared to those without pain. In this study, we treated primary microglial cultures from mice with miR-19a and miR-19b for 24 h and conducted RNA sequencing analysis. Our results showed that miR-19a and miR-19b up- and downregulate different genes according to the volcano plots and the heatmaps. miR-19a and miR-19b regulate inflammation through distinct signaling pathways. The results showed that miR-19a promotes inflammation via toll-like receptor signaling, TNF signaling, and cytokine–cytokine receptor interactions, while miR-19b increases inflammatory responses through the PI3K-Akt signaling pathway, focal adhesion, and extracellular matrix receptor interactions. The protein–protein interaction (PPI) networks used the STRING database to identify transcription factors associated with genes up- or downregulated by miR-19a and miR-19b. Key transcription factors, such as STAT1, STAT2, and KLF4 for miR-19a, and Nr4a1, Nr4a2, and Nr4a3 for miR-19b, were identified and revealed their roles in regulating neuroinflammation. This study demonstrates that miR-19a and miR-19b modulate diverse patterns of gene expression, regulate inflammation, and induce inflammatory responses in microglia.

1 August 2021 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
NLNhungoc Luong
Nhungoc Luong
JLJennifer A Lenz
Jennifer A Lenz
JMJaime Modiano
Jaime Modiano
JOJulie K. Olson
Julie K. Olson
Monocytes are among the first cells to infiltrate the tumor microenvironment. The conversion of monocytes to suppressor cells in the tumor microenvironment is crucial in evasion of the immune response and tumor maintenance. Tumor cells may secrete products that promote the conversion of monocytes to suppressor cells. Cells secrete extracellular vesicles (EVs) containing cargos of genetic materials and proteins as a way to communicate with neighboring cells. During pathologic conditions like cancers, tumor cells increase their EVs production containing microRNA, RNA, and proteins that may affect the immune cell response, contributing to the immunosuppressive microenvironment. Our studies show that EVs secreted by a wide range of murine tumor cells, including osteosarcoma, glioma, colon carcinoma, sarcoma, and melanoma, can be taken up by bone marrow–derived monocytes. The monocytes that took up the EVs secreted by tumor cells matured toward an immune-suppressive phenotype by upregulating the expression of suppressive cytokines and effector molecules. The monocytes also downregulated MHC class II and costimulatory molecules while increasing the expression of PD-L1 on their surface after taking up EVs from tumor cells. Most importantly, monocytes exposed to EVs secreted by tumor cells suppressed activated Ag-specific CD4+ T cells. These results show that tumor cells from several different tumor types secrete EVs which promote the conversion of monocytes into suppressor cells, thus promoting immune evasion. These studies suggest that EVs secreted by tumors are potentially a new target for future cancer therapy.


25 June 2026 in Journal of Neuroscience Research
Verified
Journal Article
Open access
FSFaezeh Sahebdel
Faezeh Sahebdel
RBRicardo A. Battaglino
Ricardo A. Battaglino
LMLeslie R. Morse
Leslie R. Morse
JOJulie K. Olson
Julie K. Olson
Neuroinflammation, driven by microglia activation and the production of pro‐inflammatory cytokines, has been implicated in several neurological diseases and neuropathic pain. MicroRNAs (miRNAs) have emerged as important regulators of neuroinflammatory processes. Prior studies identified elevated levels of circulating miR‐19a and miR‐19b in individuals living with chronic pain following spinal cord injury (SCI). In this study, we wanted to determine whether miR‐19a and miR‐19b have a direct effect on microglia activation, specifically pro‐inflammatory activation, associated with neuroinflammation. Microglia were activated by inflammatory stimuli in the presence of miR‐19a or miR‐19b mimics, and assessed for the expression of cytokines, chemokines, and effector molecules. The results show that miR‐19a or miR‐19b mimics increased the expression of pro‐inflammatory cytokines, chemokines, and effector molecules in microglia. The results also showed decreased expression of suppressor of cytokine signaling (SOCS) proteins, namely SOCS1 and SOCS3, in activated microglia with miR‐19a and miR‐19b mimics. Additionally, enhanced signaling through the NFκB and Jak pathways was observed with increased NFkB‐p65 and JAK1 phosphorylation in the presence of miR‐19a and miR‐19b mimics. Further results show that miR‐19a and miR‐19b inhibitors reversed these effects on activated microglia. Overall, our results demonstrate that miR‐19a or miR‐19b increased the expression of pro‐inflammatory cytokines, chemokines, and effector molecules in activated microglia. These results indicate that miR‐19a and miR‐19b can enhance microglia activation and associated inflammatory responses, which may have implications for conditions associated with neuroinflammation.